<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0229239.ref032">
 <label>32</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Schütz</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Moser</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Schwanke</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Schubert</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Luhn</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Gutic</surname>
   <given-names>E</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals</article-title>. 
  <source>J Viral Hepat</source>. 
  <year>2018</year>
  <month>7</month>;
  <volume>25</volume>(
  <issue>7</issue>):
  <fpage>870</fpage>–
  <lpage>3</lpage>. 
  <pub-id pub-id-type="doi">10.1111/jvh.12857</pub-id>
  <?supplied-pmid 29316001?>
  <pub-id pub-id-type="pmid">29316001</pub-id>
 </mixed-citation>
</ref>
